Drug intelligence / Profile preview

Sanhua Gao

Development stage: Unknown
Lead developer: Xi'an Honghui Hospital
Administration: Transdermal, Topical

Overview

Sanhua Gao is a Traditional Chinese Medicine (TCM) topical ointment used for the treatment of perioperative swelling and pain, particularly in patients with tibial plateau fractures. It is typically administered via targeted transdermal application, sometimes facilitated by a directional TCM therapy device, to reduce inflammatory edema and improve recovery outcomes following open reduction and internal fixation (ORIF) surgery. The preparation is developed and utilized by the North Campus of Xi'an Honghui Hospital and is currently being evaluated in Phase 4 clinical trials to assess its efficacy in reducing lower leg swelling and pain compared to conventional care.

Brand names: Sanhua Gao
Other names: Sanhua ointmentSanhua paste

Beyond the preview

Go deeper on Sanhua Gao.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sanhua Gao.

Explore the full profile